Bio-Rad Laboratories, Inc. BIO.B Life Science — Restructuring Charges
Discontinued — last reported Q4 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s life science — restructuring charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s life science — restructuring charges?
- Bio-Rad Laboratories, Inc. (BIO.B) reported life science — restructuring charges of $1.5M in Q4 2025.
- What does life science — restructuring charges mean?
- The cost incurred during the period to reorganize or downsize operations within the Life Science segment.
- How do you interpret life science — restructuring charges?
- High charges indicate active operational transformation, which may temporarily depress earnings but aim to improve long-term margins.
- How does life science — restructuring charges compare across companies?
- Frequently reported by peers during periods of integration or strategic pivots; often treated as a non-recurring item.